Surya Pharmaceutical Ltd.
| BSE: 532516 | Sector: Health care |
| NSE: SURYAPHARM | ISIN Code: INE249G01020 |
| BSE 00:00 | 24 Feb | Surya Pharmaceutical Ltd |
| NSE 05:30 | 01 Jan | Surya Pharmaceutical Ltd |
| OPEN | 0.22 |
| PREVIOUS CLOSE | 0.22 |
| VOLUME | 241733 |
| 52-Week high | 0.23 |
| 52-Week low | 0.00 |
| P/E | 0.02 |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.23 |
| Sell Qty | 1.00 |
Surya Pharmaceutical Ltd. (SURYAPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 934.00 | -10.75 | -1.14 | 13266.48 |
| Cipla | 762.20 | -16.50 | -2.12 | 12659.15 |
| Sun Pharma.Inds. | 532.00 | -9.05 | -1.67 | 12531.93 |
| Dr Reddy's Labs | 4517.45 | -78.00 | -1.70 | 11850.40 |
| Lupin | 940.00 | -17.95 | -1.87 | 11025.66 |
| Apollo Hospitals | 1707.30 | -43.90 | -2.51 | 8336.66 |
| Alkem Lab | 2788.20 | 3.70 | 0.13 | 6677.08 |
| Cadila Health. | 385.30 | -9.60 | -2.43 | 6347.40 |
| Glenmark Pharma. | 466.55 | -10.40 | -2.18 | 6304.87 |
| Torrent Pharma. | 2813.55 | -56.95 | -1.98 | 6168.44 |
| Divi's Lab. | 3118.15 | -17.60 | -0.56 | 4879.66 |
| Piramal Enterp. | 1462.45 | -11.80 | -0.80 | 4219.19 |
| Alembic Pharma | 1076.20 | -3.85 | -0.36 | 4132.55 |
| Abbott India | 16697.05 | 56.05 | 0.34 | 3678.60 |
| Ipca Labs. | 2005.95 | -2.45 | -0.12 | 3605.66 |
| Glaxosmi. Pharma | 1457.85 | -16.55 | -1.12 | 3224.68 |
| Jubilant Life | 814.75 | -24.95 | -2.97 | 3139.90 |
| Sanofi India | 8285.40 | -197.40 | -2.33 | 3070.60 |
| Laurus Labs | 1028.80 | -22.60 | -2.15 | 2797.34 |
| Nectar Lifesci. | 22.25 | -0.40 | -1.77 | 2784.93 |
Quick Links for Surya Pharmaceutical:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
